Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Rating of “Buy” from Brokerages

Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) have been assigned a consensus recommendation of “Buy” from the five research firms that are presently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have covered the stock […]